Test - CPHI Middle East

CPHI Middle East is the premier pharmaceutical trade exhibition and networking platform serving the Middle East and Africa, returning in 2026 to Riyadh, Saudi Arabia at the Riyadh Exhibition and Convention Centre, Malham. The event spans May 11–13 and is designed to bring together the global pharmaceutical community to explore market access opportunities, showcase innovations across the entire pharma supply chain, and connect buyers, manufacturers, suppliers, and service providers. Attendees can engage with 1,000+ exhibiting brands from over 110 countries and benefit from extensive insights into regulatory developments, manufacturing technologies, packaging solutions, APIs, excipients, and drug delivery systems, all under one roof.

The 2026 edition will feature a strong programme of expert speakers from leading global companies, offering high-level strategic and operational perspectives on key industry challenges and opportunities. Confirmed speakers include Claudia Roa (Global Sector President, Life Sciences & Healthcare at DHL), Chris Chen (Chief Executive Officer, WuXi Biologics), Marc Funk (Former CEO & Board Member, Lonza/Recipharm), Doaa Fathallah (Chief Operating Officer, Marken/UPS Healthcare), and Bijoy Sagar (EVP & Chief Information & Digital Officer, Bayer). The event also offers a comprehensive exhibitor showcase with companies such as Pharmaline, Beacon, Cooper Pharma, SPIMACO, Tabuk Pharma, Avalon, Hikma, and others represented across core sectors. This mix of thought leadership, business growth opportunities, and networking cements CPHI Middle East’s position as a must-attend event for stakeholders looking to expand in the MEA pharmaceutical market.